NCATS Launches Drug Repurposing Project with Big Pharma, Investigators | GenomeWeb

NEW YORK (GenomeWeb News) – Launching what will be the maiden initiative for the months-old National Center for Advancing Translational Sciences, National Institutes of Health Director Francis Collins today unveiled a program that will support researchers using biomarker-based studies and other approaches to repurpose compounds owned by three of the world's largest drug developers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.